PATHFINDER 2

Clinical Trial Grant

Duke Scholars

Principal Investigator Kevin Charles Oeffinger Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

GRAIL

Start Date

November 28, 2022

End Date

November 14, 2027

Administered By

Duke Cancer Institute

Awarded By

GRAIL

Start Date

November 28, 2022

End Date

November 14, 2027